Literature DB >> 3547357

[Clinical evaluation of ceftazidime and the combined administration of cefotaxime and tobramycin in the treatment of urinary tract infections. Prospective and randomized studies].

A Wiecek, F Kokot, H Andrzejowska, W Grzeszczak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3547357

Source DB:  PubMed          Journal:  Pol Tyg Lek        ISSN： 0032-3756


× No keyword cloud information.
  3 in total

1.  Urinary alanine-aminopeptidase (AAP) excretion in patients with urinary tract infection treated with ceftazidime (CAZ) or cefotaxime (CTX) plus tobramycin (TOB).

Authors:  A Wiecek; F Kokot; W Grzeszczak
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

Review 2.  Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.

Authors:  Mical Paul; Adi Lador; Simona Grozinsky-Glasberg; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2014-01-07

Review 3.  Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials.

Authors:  Mical Paul; Ishay Benuri-Silbiger; Karla Soares-Weiser; Leonard Leibovici
Journal:  BMJ       Date:  2004-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.